BLOOD cancer patients who have had two coronavirus vaccinations may still have little protection against COVID-19, according to the findings of recent research.
Lead author Dr Sheeba Irshad, a senior clinical lecturer from King’s College London, said: “COVID-19 vaccines are very effective and safe for majority of the population, but people with moderate to severe compromise of their immune system are not completely protected after the initial dose or after both doses.”
Belgique Dernières Nouvelles, Belgique Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Covid: When can I get my Covid booster jab?More than four million people have had a Covid vaccine booster dose.
Lire la suite »
COVID-19: UK 'dilly-dallying into lockdown' - take Plan B action now, warns government adviserProfessor Stephen Reicher says vaccines are 'not quite enough' on their own and 'other protections' are now needed - as a fellow expert says he is fearful of another 'lockdown Christmas'.
Lire la suite »
Lockdown 'not on the cards' as Covid booster will prevent restrictions, says RishiRISHI Sunak has said that another lockdown is “not on the cards” because Covid boosters will prevent the need for extreme coronavirus restrictions. The Chancellor admitted that this win…
Lire la suite »
UK faces ‘lockdown Christmas’ if it delays new Covid curbs, warns government adviser‘With public health measures, the time to act is immediately,’ says Peter Openshaw
Lire la suite »
Schools' Covid clampdown: More than one million students face tougher rules as cases spikeMORE THAN a million schoolchildren in the UK are facing tougher coronavirus restrictions on the urging of local authorities, with some schools closing early ahead of half term.
Lire la suite »
Winter Covid wave won’t be as bad as last year – even without ‘Plan B’📉 Modelling suggests hospital admissions will be nowhere near highs of January unless transmission soars and immunity wanes
Lire la suite »